tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
ALLO is currently covered by 10 analysts with an average price target of $12.59. This is a potential upside of $11.08 (733.77%) from yesterday's end of day stock price of $1.51.
Allogene Therapeutics's activity chart (see below) currently has 169 price targets and 138 ratings on display. The stock rating distribution of ALLO is 76.92% BUY and 23.08% HOLD.
Analysts average stock forecasts to be materialized ratio is 23.98% with an average time for these price targets to be met of 78.4 days.
Highest price target for ALLO is $8, Lowest price target is $8, average price target is $8.
Most recent stock forecast was given by BRIAN CHENG from JPMORGAN on 10-Oct-2025. First documented stock forecast 05-Nov-2018.
Currently out of the existing stock ratings of ALLO, 10 are a BUY (76.92%), 3 are a HOLD (23.08%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
2 months 2 days ago
(10-Oct-2025)
0/3 (0%)
$2.86 (55.64%)
Hold
$5
4 months 8 days ago
(04-Aug-2025)
1/7 (14.29%)
$3.06 (157.73%)
148
Buy
6 months 28 days ago
(14-May-2025)
2/9 (22.22%)
$12.2 (210.34%)
94
Buy
$10
6 months 28 days ago
(14-May-2025)
0/2 (0%)
$6.92 (224.68%)
Buy
$9
6 months 28 days ago
(14-May-2025)
2/8 (25%)
$6.54 (265.85%)
3
What is ALLO (Allogene Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on ALLO (Allogene Therapeutics) with a proven track record?
Which analyst has the most public recommendations on ALLO (Allogene Therapeutics)?
Which analyst is the currently most bullish on ALLO (Allogene Therapeutics)?
Which analyst is the currently most reserved on ALLO (Allogene Therapeutics)?
